


New Medicine Revenue
Information Services • Lake Forest, California, United States • 1-10 Employees
New Medicine revenue & valuation
| Annual revenue | $14,200,000 |
| Revenue per employee | $1,567,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Information Services industry and current estimated revenues | $45,200,000 |
| Total funding | No funding |
Key Contact at New Medicine
Katie Siafaca
President and Treasurer
Company overview
| Headquarters | P.O. BOX 909, LAKE FOREST, 92609, US |
| Phone number | +19498300448 |
| Website | |
| NAICS | 519 |
| Employees | 1-10 |
| Socials |
About New Medicine
New Medicine's Oncology Knowledgebase is a dynamic, daily updated, fully relational, user-friendly, comprehensive resource in global drug development in oncology Why use a resource like nm/OK? Unlike reports that are 'dead on arrival' nm/OK is a constantly updated comprehensive report on every aspect of oncology drug development. Drugs profiled in nm/OK - nm/OK profiles over 4,139 drugs/in vivo imaging agents in development: - 3,296 anticancer agents addressing over 100 cancer types and thousands of clinical indications. Of these, 1,695 are in active development; 821 are in clinical trials and 528 of these are targeted agents. - 757 drugs for the management of complications of cancer and its treatment (pain, infection, mucositis, emesis, etc.) - nm/OK also profiles over 552 marketed drugs (anticancer agents=335, adjuncts=197) globally, providing trial results from monotherapy and combination therapy trials. In vitro testing (IVT) products nm/OK profiles over 200 companies and hundreds of products (screening tests, diagnostics, pharmacogenomics, prognostics, disease monitoring tests, theragnostics, etc.) in the in vitro testing area in oncology. Enabling technologies/drug delivery nm/OK describes hundreds of technology platforms used to discover, evaluate, optimize, and or deliver anticancer agents such as cytotoxics, synthetic nucleic acid sequences, small molecule drugs, monoclonal antibodies, fusion proteins, etc. Targets in oncology nm/OK describes over 1,000 molecular moieties that may be target candidates of anticancer strategies or used as in vitro testing markers.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
New Medicine has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
New Medicine has never raised funding before.
Frequently asked questions
4.8
40,000 users



